DOI:
10.1055/s-00000161
The Journal of Knee Surgery
LinksClose Window
References
Delforge M, Terpos E, Richardson PG. , et al.
Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. melphalan-prednisone in the phase III VISTA trial in multiple myeloma.
Eur J Haematol 2011;
86 (05) 372-384
We do not assume any responsibility for the contents of the web pages of other providers.